AI-Powered insulin dosing shows promise for diabetes control
NCT ID NCT07291804
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether an intelligent insulin-dosing decision support system could help adults with type 2 diabetes manage their blood sugar better than standard care. 140 participants starting insulin therapy used a smart glucometer and mobile app to get algorithm-based dose recommendations. The goal was to improve blood sugar levels without increasing the risk of dangerously low blood sugar.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510630, China